Risks, Antibodies, and Antivirals Webinar
Cleveland Clinic Rheumatologist-immunologists Dr. Leonard Calabrese, and Dr. Cassandra Calabrese, as they discuss the Covid-19 Omicron variant, the use of Evusheld, and the availability and effectiveness of antivirals.
● Covid-19 Omicron variant, updated risks for rheumatic patients
● The use of Evusheld for immunocompromised patients
● The latest updates on the effectiveness and availability of two newly approved antiviral pills
Click HERE to view